The US FDA has approved new drug applications (NDAs) for a line of controlled substance products containing oxycodone hydrochloride, said partners Lehigh Valley Technologies (LVT) and Glenmark Generics Inc, a US subsidiary of the Indian firm Glenmark.
The approval gives LVT and Glenmark manufacturing and distribution rights to the only FDA-approved oxycodone immediate release capsules and oral...